INTRODUCTION
============

Laparoscopy is now considered a superb diagnostic tool and is the preferred method to explore and operate in the abdominal cavity. The gas used in videoendoscopic laparoscopic surgery to induce pneumoperitoneum (PN) is carbon dioxide (CO~2~), which is inert, blood soluble, and not explosive.^[@B1]^ Many symptoms that are reported after laparoscopy are generally attributed to CO~2~ insufflation into the peritoneal cavity. The peritoneum has a large capacity for absorption and reaction; it is one of the rich, vascularized organs with a surface lining that is coated by highly differentiated mesothelial cells. The peritoneum is able to synthesize chemokines, which are cytokines that are significant in driving different elements of inflammation.^[@B2]^ The creation of CO~2~ PN induces morphological alterations in the mesothelium, which are microscopically apparent. We have previously described a peritoneal chronical inflammation in rats 24 hours after PN and consisting mostly of eosinophils, granulocytes, mastocytes, and macrophages.^[@B3]^ These modifications appear to be related to intraabdominal CO~2~ pressure.^[@B4]^ Volz and Suematsu demonstrated ultrastructural changes after PN, such as swelling up of mesothelium and an enlargement of intercellular junctions.^[@B5],[@B6]^ The observed uncovering of the mesothelium basement membrane may be dependent from macrophage-evoked changes of peritoneal immunity and could be assessed as the main cause for surface-induced adherence. Bertram et al^[@B7]^ advised that injection and grafting of mesothelial cells into the abdomen was related to reduced development of adhesions. Thus, to decrease postinflammatory and surgical adhesions, it is important to maintain the integrity of the peritoneal surface. Leukocytes have a primary role when the peritoneal serosa is damaged. Activation of these cells and degranulation release active components, such as cytokines and growth factors.^[@B8],[@B9]^ Among the cytokines, RANTES/CCL5 (Regulated upon Activation of Normal T cell Expressed and Secreted/Chemokine \[C-C motif\] ligand 5) and MCP-1/CCL2 (Monocyte Chemoattractant Protein-1/Chemokine \[C-C motif\] ligand 2) exert proinflammatory activities. These chemokines are secreted in infectious and inflammatory diseases and mediate the recruitment of immune cells. In particular, RANTES/CCL5 is produced by different cell types, such as T lymphocytes, macrophages, platelets, and eosinophils playing an active role in the migration of these cells. Nevertheless MCP-1/CCL2 mediates monocyte and macrophage recruitment and migration to the inflammation site.^[@B10]^

Furthermore, laparoscopy causes intra-abdominal acidosis, perhaps evoked by the local decrease in partial oxygen pressure. This effect seems to have a beneficial influence on the peritoneal immune system.^[@B11]^ Following an open surgical procedure, there is a surge in proinflammatory cytokines, such as TNF-α and IL-1, that are attenuated by laparoscopy.^[@B12]--[@B14]^ Therefore, laparoscopic surgery changes not only peritoneal integrity but also its biological environment.

The study was conducted to examine the effect of CO~2~ PN on the serum levels of inflammatory cytokines and the corresponding tissue immunohistochemical analysis and expression.

MATERIALS AND METHODS
=====================

Animals
-------

The experiment was conducted as previously reported.^[@B3],[@B4]^ Twenty-five prepubertal Sprague-Dawley rats were in the object of the protocol. Animals were housed following the protocol suggested by Institutional Animal Care and Use Committee of the University of Campania "Luigi Vanvitelli," Faculty of Medicine, in agreement with the recommendations of National Institutes of Health. The rats were hosted in a stable arrangement (12 hours of daylight at a temperature of 22°C) with food and water ad libitum.

Experimental Protocol
---------------------

On the day of the study, the rats were randomized as follows: PN was evoked in two groups with CO~2~ (S1 and S2, n = 20) with a flow rate of 0.5 L/minute. In the last group (C, n = 5), only general anesthesia was executed and acted as control. The designated pressures were chosen according to our previous protocol and other studies.^[@B3],[@B4],[@B15]^

Anesthesia was induced by an intramuscular administration in the legs of the animal with a dose of 5 mg/kg tiletamine-zolazepam hydrochloride at a 1:1 ratio and a dose of 0.2 mg/kg and xylazine at a dose of 5 mg/kg into the leg of the animal. Fifteen minutes after, the abdominal wall was shaved and cleaned; a Veress needle was inserted in the abdominal cavity, and PN was created with an inflator (Storz Electronic CO~2~ Endoflator, Karl Storz GmbH & Co., Tuttlingen, Germany) that delivered medical CO~2~ at 37°C and an outflow of 0.5 L/minute for 30 minutes at different pressures (6 and 10 mm Hg). All rats were sacrificed after 24 hours from surgery with a lethal administration of tiletamine-zolazepam hydrochloride.

Cytokines in rats with PN at 6 mm Hg and 10 mm Hg and in control rats were measured. At 24 hours after PN, the serum was collected and conserved at −20°C until cytokine evaluation, and then, an enzyme-linked immunosorbent assay (ELISA) was performed. In particular, cytokine levels (IL-6, IL-1α, IL-1β, TNF-α, MIP IFNr, MCP-1, and RANTES) were quantified in serum samples, which were optimally diluted.

A multiplex assay kit manufactured by Signosis (Cat. N. EA-1201; Santa Clara, CA, USA) was used for the contemporaneous measurement of the mentioned cytokines.

All optical densities were measured at 450 nm. The levels of cytokines are expressed as ng/mL.

Histological Examination
------------------------

Immunohistochemical analysis was performed on paraffin-embedded sections following a well-established method.^[@B16]^ Primary antibodies included CCL5/RANTES AB finity recombinant rabbit oligoclonal antibody (catalog no. 710001) diluted 1:500 in PBS, rabbit polyclonal MCP-1 (ab9669, AbCam, Cambridge, UK) diluted 1:1000 in PBS. Slides were evaluated independently by two experienced pathologists (SP and OP), with good agreement (Cohen\'s κ, *P* \< .001). The κ-value between the two sets of scores was 0.82, indicating good concordance. The expression of CCL5/RANTES and MCP-1 was semi quantitatively evaluated according to the intensity of cytoplasmic tissue stain from 0 to 3 as follows: (0, 1+, 2+, 3+: no, faint, moderate, and strong reactivity, respectively). To identify the predominant lymphocyte subtype, the labeled immune cells number was determined for each slide and each antibody in all groups and is expressed as the mean of at least 10 fields at 40× magnification.

Statistical Analysis
--------------------

Variables were tested for normality and were log transformed to achieve normal distribution as appropriate. Differences between different treatments were evaluated by ANOVA to analyze the effect of each cytokine. The results are expressed as the mean ± SD. A value of *P* \< .05 was considered statistically significant.

RESULTS
=======

The rats showed no clinically relevant symptoms. To understand the effects of PN treatment on inflammatory response mediators, a probable pattern of cytokines that are involved in immunological mechanisms was examined.

The rats insufflated with 10 mm Hg and 6 mm Hg PN showed higher plasma TNF-α levels (0.32 ± 0.1 and 0.26 ± 0.04, respectively) compared to those of the control group (0.23 ± 0.01), with the 10 mm Hg PN group presenting higher levels compared to those of the 6 mm Hg PN rats with no statistical significance (*P* = .38) (**[Figure 1](#F1){ref-type="fig"}**). Similarly, the three groups had different plasma IL-6 levels, although the observed difference was not significant (10 mm Hg PN, 1.11 ± 0.26; 6 mm Hg PN, 0.93 ± 0.28; controls, 0.73 ± 0.18; *P* = .293) (**[Figure 2](#F2){ref-type="fig"}**).

![Serum TNF-α levels after PN in the control, PN 6 mm Hg, and PN 10 mm Hg groups. The data are expressed as the mean ± SD](jls0201638420001){#F1}

![Serum IL-6 levels after PN in the control, PN 6 mm Hg, and PN 10 mm Hg groups. The data are expressed as the mean ± SD](jls0201638420002){#F2}

Interestingly, PN groups showed higher RANTES levels compared to controls, and the differences were statistically significant. In particular, the mean RANTES level in the 6 mm Hg PN samples was 70.3 ± 2.26 vs 29.66 ± 4.03 in the controls (*P* = .0000). Similarly, the 10 mm Hg PN group had significantly higher RANTES levels than controls (58.23 ± 4.32 vs 29.66 ± 4.03, *P* = .0001) (**[Figure 3](#F3){ref-type="fig"}**). In addition, the levels of MCP-1 were more increased in the 6 mm Hg PN group (32.1 ± 1.63) than in the 10 mm Hg PN group (27.0 ± 9.26) compared with those of the control group (16.4 ± 9.55). However, the values between groups were not significantly different (*P* = .159) (**[Figure 4](#F4){ref-type="fig"}**). Interestingly, both RANTES and MCP-1 levels showed a trend toward higher inflammatory cytokine values in low respect to high pressure group, but they were not significant.

![Serum RANTES levels after PN in the control, PN 6 mm Hg, and PN 10 mm Hg groups. The data are expressed as the mean ± SD](jls0201638420003){#F3}

![Serum MCP-1 levels after PN in the control, PN 6 mm Hg, and PN 10 mm Hg groups. The data are expressed as the mean ± SD](jls0201638420004){#F4}

No differences were reported regarding IL-1α and MIP levels among the three groups. IL-1β value did not exceed the assay limit; however, samples from the 6 mm Hg PN group showed IL-1β concentrations that were 4-fold higher than those of the 10 mm Hg PN group.

Finally, IFN-γ levels were slightly increased in PN rats compared with those of control rats.

Histological Results
--------------------

Normal control peritoneum shows absent to faint reactivity to the anti-CCL5/RANTES antibody (**[Figure 5, A and B](#F5){ref-type="fig"}**). The visceral peritoneum of the 6 mm Hg PN group showed faint to moderate reactivity of mesothelial cells to the anti-CCL5/RANTES antibody (**[Figure 6, A and B](#F6){ref-type="fig"}**), whereas at 10 mm Hg, PN, there was strong cytoplasmic reactivity of mesothelial cells to the anti-CCL5/RANTES antibody (**[Figure 7A](#F7){ref-type="fig"}** \[arrows\]), and strong immunoreactivity was observed in omentum adipose tissue (**[Figure 7B](#F8){ref-type="fig"}** \[arrows\]) and was associated with inflammatory cells **[Figure 7B](#F7){ref-type="fig"}** \[arrow heads\]). Faint reactivity to the anti-MCP-1 antibody was also observed in the control peritoneum (**[Figure 8A](#F8){ref-type="fig"}**, \[arrows\]). Adipose tissue and the inflammatory infiltrates showed moderate to strong immunoreactivity to the anti-MCP-1 antibody in 6 mm Hg PN group (**[Figure 8B](#F8){ref-type="fig"}** \[arrows\]). Strong immunoreactivity to the MCP-1 antibody was observed both in omentum adipose tissue and inflammatory infiltrates (**[Figure 8C](#F8){ref-type="fig"}**).

![Omentum and visceral peritoneum. **A** and **B**, Normal control peritoneum showing absent to faint reactivity to the anti-CCL5/RANTES antibody. Haematoxylin counterstain. Original magnification, **A**, 20×; and **B**, 40×](jls0201638420005){#F5}

![Omentum and visceral peritoneum. **A** and **B**, CO~2~ 6 mm Hg PN showing faint to moderate reactivity to the anti-CCL5/RANTES antibody of mesothelial cells (arrows). Haematoxylin counterstaining. PN, pneumoperitoneum. Original magnification, **A**, 20×; and **B**, 40×](jls0201638420006){#F6}

![Omentum and visceral peritoneum. **A**, 10 mm Hg PN showing strong cytoplasmic reactivity to the anti-CCL5/RANTES antibody of mesothelial cells (arrows). **B**, A strong immunoreactivity is observed in omentum adipose tissue (arrows), also associated to inflammatory cells (head arrows). Haematoxylin counterstaining. PN, pneumoperitoneum. Original magnification, **A**, 20×; and **B**, 40×](jls0201638420007){#F7}

![Omentum and visceral peritoneum. **A**, A faint reactivity to the anti-MCP1 antibody is observed in normal control peritoneum (arrows). **B**, CO~2~ 6 mm Hg PN: adipose tissue and the inflammatory infiltrate showing moderate to strong immunoreactivity to the anti-MCP1 antibody (arrows). **C**, CO~2~ 10 mm Hg PN: a strong immunoreactivity to MCP1 antibody is observed both in omentum adipose tissue and inflammatory infiltrate. Haematoxylin counterstain. Original magnification, **A**, 20×; and **B** and **C**, 40×](jls0201638420008){#F8}

DISCUSSION
==========

Laparoscopy is widely used and well incorporated in clinical practice as the preferred, minimally invasive technique for operating in the abdominal cavity. The induced PN modifies the peritoneal environment. The gas that is usually employed to lead to PN is CO~2~. When the abdomen is distended by CO~2~, it exerts a direct pressure on peritoneal cells and reacts with the H~2~O found in peritoneal liquid. This phenomenon decreases the pH of abdominal cavity and determines an environment that changes the defense mechanisms of the abdominal cavity,^[@B17],[@B18]^ which is an element in reducing the inflammatory response.^[@B11]^

Vascularized tissue, such as peritoneum, replies to chemical or physical insult through an inflammatory reaction. Soluble molecules such as chemokines have been demonstrated to stimulate diverse inflammatory factors, such as leukocyte influx.^[@B9]^

The peritoneum has a great capacity for absorption and action through mesothelial cells, which synthesize cytokines and chemokines that are primary factors in tissue inflammation.

In previous works, we showed that PN causes peritoneal inflammation and the activation of inflammatory cells that release substances responsible for the increase in vascular permeability, complement, and opsin.^[@B3],[@B4]^ To understand the effects of laparoscopy with CO~2~ PN on mediators of inflammatory responses, the cytokines involved in immunological responses were examined. Several papers have confirmed a considerable increase in some cytokines.^[@B19],[@B20]^ IL-6 represents the most important cytokine determined postoperatively, followed by TNF-α. In our experimental protocol, serum levels of IL-6, TNF-α, IL-1α, IFN-γ, MCP-1/CCL2, IL-1β, RANTES/CCL5, and MIP were assessed after inducing PN at two different pressures and in the control group. We showed that PN modifies serum concentrations and tissue expression of the chemokines CCL5 and CCL2. RANTES/CCL5 showed the most dramatic increase.

RANTES/CCL5 controls the activation and recruitment of inflammatory cells. Moreover, since chemokine receptors are also expressed on other cells, they may also play a role in other regions of the organism, as well as in mechanisms of tissue repair and scarring.^[@B21]^ There are many studies that establish a role of CCL5 in disease activity and in leading to leukocyte enrollment, neovascularization, and formation of fibrous tissue.^[@B21]^ In our study, we showed that there was not only a significant modification of the serum levels but also strong tissue expression, suggesting the influence of this chemokine in the development of inflammation. Kawashima et al^[@B9]^ showed that during laparotomy, a large amount of CCL5 was produced, and they postulated that this increase may be indicative of mesothelial cell injury. They noted that in the presence of lipopolysaccharide, there was no significant production of CCL5 by exudate cells.^[@B9]^ Our study showed significant modifications in RANTES/CCL5 serum levels in the groups insufflated with CO~2~ compared with those of the control group. This chemokine, together with CCL2, were also strongly expressed in peritoneal tissues, as revealed by histological examination. Therefore, we may speculate that these modifications are directly indicative of mesothelial cellular injury.

Interestingly, we found a trend toward higher inflammatory cytokine levels in the low-pressure group. In our opinion, these results could be related to the experimental model and its variables. However, we might speculate that low pressure is associated with higher CO~2~ absorption and mesothelial oxidative stress that evoked a different cytokines\' responses.^[@B8],[@B22]^

Cytokines have been identified as important mediators in both acute and chronic human inflammatory disorders. The role of inflammatory mediators is not completely understood, especially in morbidity and mortality of intra-abdominal sepsis, and there is no consensus on the clinical use of mediators in diagnosing or managing this problem. However, recently, many researchers have tried to evaluate cytokines and chemokines in order to define a diagnostic and a therapeutic role. In Pediatric appendicitis, through an analysis of inflammatory mediators, the assessment of previously identified mediators such RANTES and MCP-1 demonstrate statistical differences in children with appendicitis when compared with those with abdominal pain not due to appendicitis. Therefore, the cytokines mediate their response in relation to a different inflammatory stimulus.^[@B23]^ If there is a difference in cytokine response between normal, infected, or previously inflamed peritoneum clearly more studies are necessary to understand how cytokines relate each other and how we could modify this clinical status in order to add a benefit for the patient.

As previously stated, cellular components of mesothelium contribute not only to inflammation but also to tissue repair. PN causes changes in mesothelial cells by extracting the basal membrane and thus leads to the development of postsurgical adherences.^[@B3]--[@B5]^

Experimental protocols have reported that mesothelium undergoes structural and functional modifications, which are consistent with a mesothelial-mesenchymal transition after an inflammatory stimulation. The capacity of the mesothelium to be a source of fibrogenic cells suggests that it might be an active player in serous fibrosis.^[@B2]^

Following serous lesions, mesothelial cells secrete several coagulation factors and inflammatory mediators that may induce the development of adherences.^[@B24]^ It has been shown that in peritoneal dialysis or in infection of the abdominal cavity, leukocytes migrate from the vasculature into the peritoneal space. Macrophages are able to release cytokines such as TNF-α or IL-1β that stimulate to produce RANTES. This effect further attracts more white blood cells to the place of trauma and allows adhesion and recruitment of leukocyte through the mesothelium.^[@B2]^ Therefore, different strategies and actions have been proposed to avoid damage to the peritoneal membrane, as well as surgical fluid barriers (4% icodextrin).^[@B24]^

Postoperative intra-abdominal adhesions are an important clinical and surgical problem. They are a relevant cause of pain, female sterility, and bowel occlusion that can occur for up to 20 years.^[@B25]--[@B27]^

When the normal peritoneal healing process is altered, the development of fibrous tissue is thought to occur.^[@B25]^ The influx of cells such as lymphocytes, fibroblasts, and macrophages have a pivotal role in the serosal layer repair and are influenced by PN.^[@B24]^ It has been recently discovered, in a murine model, that chemokines are involved in the postoperative adhesions through the mesothelium cellular assembling^[@B9]^ by the self activation of peritoneal macrophages.

To regulate and mitigate this process, many anti-inflammatory and anticoagulatory substances, such as steroids and heparin, have been tested at the systemic and local levels, but none of these has proven to be effective.^[@B24]^ Satisfactory results in preventing adhesion development have been obtained experimentally through mesothelial cell transplantation.^[@B7],[@B28]^ Clearly a better understanding the potential role of RANTES and MCP-1 and the process that cause the development of adhesion formation and inflammation, and how some recognized injuries such as infections or neoplastic condition may have an increased detrimental effect would add a step further in developing new strategies of care. However, since we have conducted our study in a clean peritoneal environment, we could not evaluate the differences in cytokine response in infection and or neoplastic conditions; nonetheless, when a safe mesothelial environment is present, obtaining less inflammatory cytokine response in the postoperative period as in clean surgery could be considered beneficial to the patient, but to date, targeted therapies remain experimental. We acknowledge that systemic consequences of peritoneal treatments should be investigated.

As reported above, the use of CO~2~ for PN, the flow rate and the selected intra-abdominal pressure can cause biochemical and morphological modifications, hypoxia, and dehydration to mesothelium.^[@B3],[@B4],[@B28],[@B29]^ The development of laparoscopic surgical techniques, the use of modern devices and image magnification support less invasive surgery that can avoid the insult of mesothelial cells and bleeding, which are the origins of adhesions. To avoid these complications, some researchers have tried to change the physical qualities of CO~2,~ such as humidifying, raising the temperature and the altering composition of the gas used for insufflation.^[@B2],[@B30]^ Although more studies are needed looking at the potential role of RANTES and MCP-1, we suggest that targeting these chemokines could be beneficial in preventing postoperative peritoneal modifications such inflammation and adhesions. In terms of benefits for the patient, less pain, and fewer postoperative complications could be associated with minimally invasive surgery.

CONCLUSION
==========

In conclusion, we have demonstrated in this study that PN modifies the serum and the corresponding tissue expression of the chemokines CCL5 and CCL2, which are involved in tissue inflammation and response to insults exerted by chemical and physical CO~2~ action on the abdominal cavity. Targeting these factors appears to be an important means of providing an additional benefit to laparoscopy by modifying peritoneal inflammation and potential subsequent peritoneal adhesions. More studies are necessary to clarify these mechanisms and their possible influence in humans.
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